RAEDYONT Trademark
Trademark Overview
On Wednesday, July 3, 2024, a trademark application was filed for RAEDYONT with the United States Patent and Trademark Office. The USPTO has given the RAEDYONT trademark a serial number of 79404384. The federal status of this trademark filing is APPROVED FOR PUBLICATION as of Sunday, December 22, 2024. This trademark is owned by Novartis AG. The RAEDYONT trademark is filed in the Pharmaceutical Products category with the following description:
Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the p...
General Information
| Serial Number | 79404384 |
| Word Mark | RAEDYONT |
| Filing Date | Wednesday, July 3, 2024 |
| Status | 680 - APPROVED FOR PUBLICATION |
| Status Date | Sunday, December 22, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | NOT AVAILABLE |
Trademark Statements
| Goods and Services | Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for ophthalmological use; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma. |
Classification Information
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, September 19, 2024 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | Novartis AG |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | CH |
Trademark Events
| Event Date | Event Description |
| Thursday, September 12, 2024 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
| Thursday, September 19, 2024 | LIMITATION FROM ORIGINAL APPLICATION ENTERED |
| Monday, October 7, 2024 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Monday, October 7, 2024 | APPLICATION FILING RECEIPT MAILED |
| Friday, October 11, 2024 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Friday, October 11, 2024 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Friday, October 11, 2024 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| Friday, October 11, 2024 | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS |
| Friday, October 11, 2024 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| Saturday, December 21, 2024 | ASSIGNED TO EXAMINER |
| Sunday, December 22, 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
